Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity.

Clinical trial NCT05470166 · COMPLETED

Trial details

NCT number: NCT05470166
Sponsor: Alexandria University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

ERAS Lidocaine Cancer of Pancreas Natural Killer Cell Cytokine Production

Start date: 2022-04-20
Primary completion: 2024-01-17
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.